XML 63 R38.htm IDEA: XBRL DOCUMENT v3.24.1
Related Party Transactions (Tables)
 12 Months Ended
Dec. 31, 2023
Related Party Transactions [Abstract]  
Schedule of Remuneration of Directors and Key Management Personnel Remuneration attributed to key management personnel are summarized as follows:
   December 31,
2023		   December 31,
2022		 
Consulting fees  $230,000   $215,078 
Salaries   633,957    403,180 
Share-based compensation   357,349    129,980 
   $1,221,306   $748,238 
Schedule of fair value of the options granted to each individual and the related expense Details of the fair value granted to each individual and the related expense recorded for the year ended December 31, 2023 is as follow:
   December 31,
2023		   December 31,
2022		   Fair value of
stock options
granted		 
Braeden Lichti, Former Chairman and President  $6,563   $14,181   $50,995 
Graydon Bensler, CFO and Director   6,563    14,181    50,995 
Jordan Plews, CEO and Director   6,563    14,181    50,995 
Tim Sayed, Chief Medical Officer   6,563    14,181    50,995 
Jeffrey Parry, Director   29,855    -    107,669 
Julie Daley, Director   98,613    -    210,245 
Crystal Muilenburg, Director   82,252    -    210,245 
Brenda Buechler, Chief Marketing Officer   62,705    -    143,671 
Christoph Kraneiss, Chief Commercial Officer   57,672    -    121,243 
   $357,349   $56,724   $997,053